Home » Misc » Depression getting better

Depression getting better


SAMHSA’s National Helpline | SAMHSA

Your browser is not supported

Switch to Chrome, Edge, Firefox or Safari

Main page content

  • SAMHSA’s National Helpline is a free, confidential, 24/7, 365-day-a-year treatment referral and information service (in English and Spanish) for individuals and families facing mental and/or substance use disorders.

    Also visit the online treatment locator.

SAMHSA’s National Helpline, 1-800-662-HELP (4357) (also known as the Treatment Referral Routing Service), or TTY: 1-800-487-4889 is a confidential, free, 24-hour-a-day, 365-day-a-year, information service, in English and Spanish, for individuals and family members facing mental and/or substance use disorders. This service provides referrals to local treatment facilities, support groups, and community-based organizations.

Also visit the online treatment locator, or send your zip code via text message: 435748 (HELP4U) to find help near you. Read more about the HELP4U text messaging service.

The service is open 24/7, 365 days a year.

English and Spanish are available if you select the option to speak with a national representative. Currently, the 435748 (HELP4U) text messaging service is only available in English.

In 2020, the Helpline received 833,598 calls. This is a 27 percent increase from 2019, when the Helpline received a total of 656,953 calls for the year.

The referral service is free of charge. If you have no insurance or are underinsured, we will refer you to your state office, which is responsible for state-funded treatment programs. In addition, we can often refer you to facilities that charge on a sliding fee scale or accept Medicare or Medicaid. If you have health insurance, you are encouraged to contact your insurer for a list of participating health care providers and facilities.

The service is confidential. We will not ask you for any personal information. We may ask for your zip code or other pertinent geographic information in order to track calls being routed to other offices or to accurately identify the local resources appropriate to your needs.

No, we do not provide counseling. Trained information specialists answer calls, transfer callers to state services or other appropriate intake centers in their states, and connect them with local assistance and support.

  • Suggested Resources

    What Is Substance Abuse Treatment? A Booklet for Families
    Created for family members of people with alcohol abuse or drug abuse problems. Answers questions about substance abuse, its symptoms, different types of treatment, and recovery. Addresses concerns of children of parents with substance use/abuse problems.

    It's Not Your Fault (NACoA) (PDF | 12 KB)
    Assures teens with parents who abuse alcohol or drugs that, "It's not your fault!" and that they are not alone. Encourages teens to seek emotional support from other adults, school counselors, and youth support groups such as Alateen, and provides a resource list.

    After an Attempt: A Guide for Taking Care of Your Family Member After Treatment in the Emergency Department
    Aids family members in coping with the aftermath of a relative's suicide attempt. Describes the emergency department treatment process, lists questions to ask about follow-up treatment, and describes how to reduce risk and ensure safety at home.

    Family Therapy Can Help: For People in Recovery From Mental Illness or Addiction
    Explores the role of family therapy in recovery from mental illness or substance abuse. Explains how family therapy sessions are run and who conducts them, describes a typical session, and provides information on its effectiveness in recovery.

    For additional resources, please visit the SAMHSA Store.

Last Updated: 08/30/2022

Alcohol, Tobacco, and Other Drugs

Your browser is not supported

Switch to Chrome, Edge, Firefox or Safari

Misusing alcohol, tobacco, and other drugs can have both immediate and long-term health effects.

The misuse and abuse of alcohol, tobacco, illicit drugs, and prescription medications affect the health and well-being of millions of Americans. NSDUH estimates allow researchers, clinicians, policymakers, and the general public to better understand and improve the nation’s behavioral health. These reports and detailed tables present estimates from the 2021 National Survey on Drug Use and Health (NSDUH).

Alcohol

Data:

  • Among the 133.1 million current alcohol users aged 12 or older in 2021, 60.0 million people (or 45.1%) were past month binge drinkers. The percentage of people who were past month binge drinkers was highest among young adults aged 18 to 25 (29.2% or 9.8 million people), followed by adults aged 26 or older (22.4% or 49.3 million people), then by adolescents aged 12 to 17 (3.8% or 995,000 people). (2021 NSDUH)
  • Among people aged 12 to 20 in 2021, 15.1% (or 5.9 million people) were past month alcohol users. Estimates of binge alcohol use and heavy alcohol use in the past month among underage people were 8.3% (or 3.2 million people) and 1.6% (or 613,000 people), respectively. (2021 NSDUH)
  • In 2020, 50.0% of people aged 12 or older (or 138.5 million people) used alcohol in the past month (i.e., current alcohol users) (2020 NSDUH)
  • Among the 138.5 million people who were current alcohol users, 61.6 million people (or 44. 4%) were classified as binge drinkers and 17.7 million people (28.8% of current binge drinkers and 12.8% of current alcohol users) were classified as heavy drinkers (2020 NSDUH)
  • The percentage of people who were past month binge alcohol users was highest among young adults aged 18 to 25 (31.4%) compared with 22.9% of adults aged 26 or older and 4.1% of adolescents aged 12 to 17 (2020 NSDUH)
  • Excessive alcohol use can increase a person’s risk of stroke, liver cirrhosis, alcoholic hepatitis, cancer, and other serious health conditions
  • Excessive alcohol use can also lead to risk-taking behavior, including driving while impaired. The Centers for Disease Control and Prevention reports that 29 people in the United States die in motor vehicle crashes that involve an alcohol-impaired driver daily

Programs/Initiatives:

  • STOP Underage Drinking interagency portal - Interagency Coordinating Committee on the Prevention of Underage Drinking
  • Interagency Coordinating Committee on the Prevention of Underage Drinking
  • Talk. They Hear You.
  • Underage Drinking: Myths vs. Facts
  • Talking with your College-Bound Young Adult About Alcohol

Relevant links:

  • National Association of State Alcohol and Drug Abuse Directors
  • Department of Transportation Office of Drug & Alcohol Policy & Compliance
  • Alcohol Policy Information Systems Database (APIS)
  • National Institute on Alcohol Abuse and Alcoholism

Tobacco

Data:

  • In 2020, 20.7% of people aged 12 or older (or 57.3 million people) used nicotine products (i.e., used tobacco products or vaped nicotine) in the past month (2020 NSDUH)
  • Among past month users of nicotine products, nearly two thirds of adolescents aged 12 to 17 (63.1%) vaped nicotine but did not use tobacco products. In contrast, 88.9% of past month nicotine product users aged 26 or older used only tobacco products (2020 NSDUH)
  • Tobacco use is the leading cause of preventable death, often leading to lung cancer, respiratory disorders, heart disease, stroke, and other serious illnesses. The CDC reports that cigarette smoking causes more than 480,000 deaths each year in the United States
  • The CDC’s Office on Smoking and Health reports that more than 16 million Americans are living with a disease caused by smoking cigarettes

Electronic cigarette (e-cigarette) use data:

  • In 2021, 13.2 million people aged 12 or older (or 4.7%) used an e-cigarette or other vaping device to vape nicotine in the past month. The percentage of people who vaped nicotine was highest among young adults aged 18 to 25 (14.1% or 4.7 million people), followed by adolescents aged 12 to 17 (5.2% or 1.4 million people), then by adults aged 26 or older (3.2% or 7.1 million people).
  • Among people aged 12 to 20 in 2021, 11.0% (or 4.3 million people) used tobacco products or used an e-cigarette or other vaping device to vape nicotine in the past month. Among people in this age group, 8.1% (or 3.1 million people) vaped nicotine, 5.4% (or 2.1 million people) used tobacco products, and 3. 4% (or 1.3 million people) smoked cigarettes in the past month. (2021 NSDUH)
  • Data from the Centers for Disease Control and Prevention’s 2020 National Youth Tobacco Survey. Among both middle and high school students, current use of e-cigarettes declined from 2019 to 2020, reversing previous trends and returning current e-cigarette use to levels similar to those observed in 2018
  • E-cigarettes are not safe for youth, young adults, or pregnant women, especially because they contain nicotine and other chemicals

Resources:

  • Tips for Teens: Tobacco
  • Tips for Teens: E-cigarettes
  • Implementing Tobacco Cessation Programs in Substance Use Disorder Treatment Settings
  • Synar Amendment Program

Links:

  • Truth Initiative
  • FDA Center for Tobacco Products
  • CDC Office on Smoking and Health
  • National Institute on Drug Abuse: Tobacco, Nicotine, and E-Cigarettes
  • National Institute on Drug Abuse: E-Cigarettes

Opioids

Data:

  • Among people aged 12 or older in 2021, 3. 3% (or 9.2 million people) misused opioids (heroin or prescription pain relievers) in the past year. Among the 9.2 million people who misused opioids in the past year, 8.7 million people misused prescription pain relievers compared with 1.1 million people who used heroin. These numbers include 574,000 people who both misused prescription pain relievers and used heroin in the past year. (2021 NSDUH)
  • Among people aged 12 or older in 2020, 3.4% (or 9.5 million people) misused opioids in the past year. Among the 9.5 million people who misused opioids in the past year, 9.3 million people misused prescription pain relievers and 902,000 people used heroin (2020 NSDUH)
  • According to the Centers for Disease Control and Prevention’s Understanding the Epidemic, an average of 128 Americans die every day from an opioid overdose

Resources:

  • Medication-Assisted Treatment
  • Opioid Overdose Prevention Toolkit
  • TIP 63: Medications for Opioid Use Disorder
  • Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings
  • Opioid Use Disorder and Pregnancy
  • Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants
  • The Facts about Buprenorphine for Treatment of Opioid Addiction
  • Pregnancy Planning for Women Being Treated for Opioid Use Disorder
  • Tips for Teens: Opioids
  • Rural Opioid Technical Assistance Grants
  • Tribal Opioid Response Grants
  • Provider’s Clinical Support System - Medication Assisted Treatment Grant Program

Links:

  • National Institute on Drug Abuse: Opioids
  • National Institute on Drug Abuse: Heroin
  • HHS Prevent Opioid Abuse
  • Community Anti-Drug Coalitions of America
  • Addiction Technology Transfer Center (ATTC) Network
  • Prevention Technology Transfer Center (PTTC) Network

Marijuana

Data:

  • In 2021, marijuana was the most commonly used illicit drug, with 18. 7% of people aged 12 or older (or 52.5 million people) using it in the past year. The percentage was highest among young adults aged 18 to 25 (35.4% or 11.8 million people), followed by adults aged 26 or older (17.2% or 37.9 million people), then by adolescents aged 12 to 17 (10.5% or 2.7 million people).
  • The percentage of people who used marijuana in the past year was highest among young adults aged 18 to 25 (34.5%) compared with 16.3% of adults aged 26 or older and 10.1% of adolescents aged 12 to 17 (2020 NSDUH)
  • Marijuana can impair judgment and distort perception in the short term and can lead to memory impairment in the long term
  • Marijuana can have significant health effects on youth and pregnant women.

Resources:

  • Know the Risks of Marijuana
  • Marijuana and Pregnancy
  • Tips for Teens: Marijuana

Relevant links:

  • National Institute on Drug Abuse: Marijuana
  • Addiction Technology Transfer Centers on Marijuana
  • CDC Marijuana and Public Health

Emerging Trends in Substance Misuse:

  • Methamphetamine—In 2019, NSDUH data show that approximately 2 million people used methamphetamine in the past year. Approximately 1 million people had a methamphetamine use disorder, which was higher than the percentage in 2016, but similar to the percentages in 2015 and 2018. The National Institute on Drug Abuse Data shows that overdose death rates involving methamphetamine have quadrupled from 2011 to 2017. Frequent meth use is associated with mood disturbances, hallucinations, and paranoia.
  • Cocaine—In 2019, NSDUH data show an estimated 5.5 million people aged 12 or older were past users of cocaine, including about 778,000 users of crack. The CDC reports that overdose deaths involving have increased by one-third from 2016 to 2017. In the short term, cocaine use can result in increased blood pressure, restlessness, and irritability. In the long term, severe medical complications of cocaine use include heart attacks, seizures, and abdominal pain.
  • Kratom—In 2019, NSDUH data show that about 825,000 people had used Kratom in the past month. Kratom is a tropical plant that grows naturally in Southeast Asia with leaves that can have psychotropic effects by affecting opioid brain receptors. It is currently unregulated and has risk of abuse and dependence. The National Institute on Drug Abuse reports that health effects of Kratom can include nausea, itching, seizures, and hallucinations.

Resources:

  • Tips for Teens: Methamphetamine
  • Tips for Teens: Cocaine
  • National Institute on Drug Abuse

More SAMHSA publications on substance use prevention and treatment.

Last Updated: 01/05/2023

90,000 psychotherapist spoke about two types of depression that treats

fresh number

RG-Nedeli

Rodina

Homeland

Tedented applications

Union

Fresh number

03.01.2022 16:23 9000

Category:

2222 Society

Vera Chereneva (St. Petersburg)

Depression is a serious disease that requires proper treatment. At the same time, it is very important to diagnose it correctly, because the depressions themselves are divided into two types and the treatment for them is different, according to Doctor Peter with reference to the psychotherapist, head of the department for the treatment of borderline mental disorders and psychotherapy of the Bekhterev National Medical Research Center Tatyana Karavaeva.

First of all, the psychotherapist draws attention to the fact that it is incorrect to call depression a bad mood or despondency. Depression has certain symptoms, the first, of course, is mood. With depression, it is reduced for more than two weeks in a row without a specific reason, a person experiences longing, guilt, and hopelessness. Also, citizens are faced with difficult thinking, unwillingness to show some kind of activity, it is difficult for them to get up in the morning, communicate, and go about their daily activities. Depression is characterized by sleep disturbance, a change in appetite, and in a short time people can lose 10-15 kilograms, but it happens the other way around, when the appetite rises sharply.

But depression is different. Tatyana Karavaeva says that psychotherapists distinguish between endogenous and psychogenic depression.

The first type is caused by chemical processes in the brain, when the content of serotonin and other neurotransmitters decreases. Endogenous depression is characterized by early awakenings, when people wake up at 5-6 in the morning and no longer fall asleep, in the first half of the day they feel the worst due to a decrease in serotonin levels. Toward evening, the concentration of serotonin in the body grows, it becomes a little easier.

This type of depression is also characterized by masks, that is, unusual symptoms. Patients complain of pain in the heart, arrhythmia, heartburn, bloating, difficulty breathing. It is not easy to diagnose masked depression, people undergo many examinations by doctors in search of the cause of the deterioration in well-being.

Psychogenic depression of another kind. Its cause is life's difficulties, when a person loses a loved one, becomes unemployed, or, for example, gets divorced. If endogenous depression most often manifests itself in autumn or spring, then psychogenic depression is in no way connected with the season, the reason is exclusively in a negative event.

In case of psychogenic depression, a person cannot fall asleep for a long time because of disturbing thoughts, a bad mood haunts him regardless of the time of day, covers him with a wave of melancholy, relief comes only when he manages to get distracted.

If a person can cope with despondency or a bad mood, as a rule, on his own, then depression should be treated by a specialist, emphasizes Tatyana Karavaeva. This is especially true of endogenous depression, where the main method is the normalization of the balance of essential substances in the body. But drugs are also used in the treatment of psychogenic depression, they are an additional support for cognitive-behavioral psychotherapy.

It is also impossible for citizens to self-diagnose themselves, as a rule, there is no magic analysis that would accurately indicate depression, the symptoms of the disease are still individual, and even psychotherapists with extensive experience conduct a long survey of the patient to understand whether they deal with depression and, if so, what type it is.

Tatyana Karavaeva also does not recommend leaving depression without treatment. This disease, like many others, does not go away on its own, and over time, the symptoms can only get worse.

HealthSt. PetersburgNorth-WestIn the regions

The main thing today

  • Zakharova believes that Zelensky's idea to rename the Russian Federation into "Muscovy" proves attempts to create "anti-Russia"

  • Marochko: Kiev security forces in Artemovsk transport ammunition in ambulances

  • Li Qiang became the Prime Minister of China

  • American politician Yang: Entering the NATO troops to Ukraine will provoke the Third World War

  • Readers of the Daily Mail condemned Sunak's plan to refuse negotiations from the Russian Federation to the VSU VSU

90,000 depression - the main reason for the disability in the world
9000 This diagnosis is emptied. set erroneously. Depression is a disease that has many causes and about which we still do not know much.

Sadness, dark thoughts, low self-esteem, loss of interest or inability to enjoy... Depression is not just a blues, but a real illness. It affects all aspects of daily life and is accompanied by an increased risk of suicide. It can lead to the formation of various addictions, as well as heart disease, diabetes or sexual disorders.

Many factors are involved in the development of depression. Vulnerability factors are at the basis, for example, if a person was a victim of abuse in childhood. The development of depression is usually preceded by the impact of so-called trigger factors. They can be a breakup in a relationship, the death of a loved one, or financial problems.

Apparently, genetic factors also play a certain role, which makes it possible to speak of hereditary predisposition. Chronic illness, smoking, dependence on alcohol or other psychoactive substances, and even an unbalanced diet can also increase the risk of depression.

322 million

people living with depression in 2017 1

+ 18. 4% 2

Less than half of people with depression receive antidepressant medication. 3

GREAT UNDERSTANDING OF THE CAUSES OF DEPRESSION

DISTURBANCES IN THE OPERATION OF THE SYSTEM OF NEURO-MEDIATORS

In people with depression, the biochemical processes occurring in the brain are disturbed. This disorder can manifest itself as a deficiency or imbalance in the content of one or more types of neurotransmitters - molecules that are released from the terminal part of the neuron (at the synapse) and act as carriers of chemical signals in the brain. Depression disrupts the balance of three neurotransmitters: serotonin, norepinephrine, and dopamine. They are involved in the regulation of mood and behavior, and their function can be restored with the help of antidepressants.

SYMPTOMS

According to guidelines issued by the World Health Organization and republished by the French health authority (Haute Autorité de Santé) in October 2017, “an episode of depression is characterized by the presence of at least two of the following three main symptoms (see infographic) for two consecutive weeks with a certain degree of severity; they must be different from the patient's previous condition and cause significant distress. "

Depressive episodes usually resolve after a few weeks or months with treatment or spontaneously. This state is called remission.

If subsequent episodes of depression do not recur, recovery is declared, but this rarely happens. In 50–80% of cases, a new episode occurs within the next 5 years. 6 Depression is considered chronic when certain symptoms persist, sometimes less severely, for at least 2 years.

TREATMENTS

Psychotherapy is recommended regardless of the severity of the depression.

Several types of psychotherapy are used, including supportive, cognitive-behavioral, and analytic-based psychotherapies, as well as psychotherapies based on individual, family, and group sessions.

Relatives and friends invariably play a special role in the treatment of the patient. The patient's expression of his suffering and his acceptance of help are of the utmost importance for successful treatment.

In addition to psychotherapy, the use of drugs, in particular antidepressants, is most often useful or even necessary.

Antidepressants are recommended for moderate to severe episodes of depression.

There are several classes of antidepressants. Most of them target nerve cells that release serotonin, norepinephrine, or dopamine. Their action is realized through various mechanisms through which the concentration of neurotransmitters increases or the nerve circuits damaged due to depression are restored.

The physician selects the antidepressant that is most appropriate for the patient, based on the patient's symptoms, medical history, past or current conditions and treatment. The effectiveness of antidepressants usually becomes noticeable only after a few weeks.

TWO PHASES OF TREATMENT (THREE IN THE EVENT OF RECURRENCE):

  • The acute phase (6 to 12 weeks) is needed to overcome the current episode of depression.
  • Consolidation phase (4 to 6 months) aims to reduce the risk of disease recurrence in the short term.
  • Maintenance phase: After three episodes of depression, treatment can be given for several years to prevent relapse.

In most cases, treatment is carried out on an outpatient basis (at the patient's home) under the regular supervision of a healthcare professional. However, sometimes a patient may require emergency care or an episode of depression may be resistant to traditional medications. In this case, hospitalization may be considered.

THE ROLE OF SERVIER

For more than 30 years, Servier has provided medical solutions to people who suffer from depression. Recently, the attention of our group has been focused, in particular, on the development of a digital cognitive-behavioral approach.

It combines a cognitive approach, which focuses on correcting the thoughts that keep the patient in a state of emotional decline, and a behavioral approach, which focuses on correcting inappropriate behavior. The goal of therapy is for patients to adopt a new way of thinking and develop optimal behavior.

RECURRENCE PREVENTION MEASURES

  1. Incorporate regular, moderate-intensity physical activity into your daily routine
    Exercise (walking, running, swimming, cycling) at the recommended frequency of 30-40 minutes 5 times a week.
  2. Eat a balanced diet
    A diet rich in fresh fruits and vegetables, fish and seafood, vegetable oils and whole grains. This type of food is high in essential fatty acids, vitamin B12, selenium, zinc, and iron, a lack of which increases the risk of depression.
  3. Discuss your psychological problems without delay
    Talking to family, friends or a doctor can help prevent a relapse of depression. In addition, there are communities that provide the necessary assistance to those in need

Find out more in the brochure "BE HAPPY!" developed with the support of Servier for people with depression

This material was created jointly by people suffering from or recovering from depression who are members of the GAMIAN-Europe group, which brings together patient organizations from around Europe, and Servier.

*THIS MATERIAL IS NOT A CALL FOR SELF-TREATMENT.
CONTRAINDICATIONS, CONSULT HEALTH PROFESSIONAL NEEDED

(1) (2) (3) WHO Report: Depression and other common mental disorders 2017 https://www.

Learn more